Thomas joined the Post-Graduate Fellowship program at IHME in 2012 and worked on the Access, Bottlenecks, Costs, and Equity research team, a collaborative project with UNICEF to provide quality evidence for improving the equity and cost-effectiveness of health systems. As part of this project, he examined the cost-effectiveness of antiretroviral therapy in different countries, including his home country of Kenya.
After IHME, Thomas went on to pursue a PhD with the University of Washington’s Department of Epidemiology and was an International Scholar in the International AIDS Research and Training Program. In addition, he went on to work as a Research Officer at the Center for Microbiology Research at the Kenya Medical Research Institute.
Di Giorgio L, Moses MW, Fullman N, Wollum A, Conner RO, Achan J, Achoki T, Bannon KA, Burstein R, Dansereau E, DeCenso B, Delwiche K, Duber HC, Gakidou E, Gasasira A, Haakenstad A, Hanlon M, Ikilezi G, Kisia C, Levine AJ, Maboshe M, Masiye F, Masters SH, Mphuka C, Njuguna P, Odeny TA, Okiro EA, Roberts DA, Murray CJL, Flaxman AD. The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia. BMC Medicine. 2016 20 July. doi: 10.1186/s12916-016-0653-
Odeny TA, DeCenso B, Dansereau E, Gasasira A, Kisia C, Njuguna P, Haakenstad A, Gakidou E, Duber HD. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya. Journal of the International AIDS Society. 2015 Oct 26; 18:20019. doi: 10.7448/IAS.18.1.20019.
Duber HC, Dansereau E, Masters SH, Achan J, Burstein R, DeCenso B, Gasasira A, Ikilezi G, Kisia C, Masiye F, Njuguna P, Odeny T, Okiro E, Roberts DA, Gakidou E. Uptake of WHO recommendations for first-line antiretroviral therapy in Kenya, Uganda, and Zambia. PLOS One. 2015 March 25. doi: 10.1371/journal.pone.0120350.